Results 81 to 90 of about 979 (130)

Therapeutic Vaccines for Head and Neck Squamous Cell Carcinoma and Nasopharyngeal Carcinoma. [PDF]

Vaccines (Basel)
Baliton M, Alfatlawi D, Attarian S, Nabar R, Villaflor V.   +4 more
europepmc   +1 more source

Immune responses underpinning acute co-infections with unrelated viruses: timing and location matter. [PDF]

Int Immunol
Foo IJH, Kedzierski L, Kedzierska K.
europepmc   +1 more source

The current landscape of therapeutic vaccination approaches for treatment of HPV-dependent malignancies. [PDF]

NPJ Vaccines
Audouze-Chaud J, Schlosser AK, Riemer AB.   +2 more
europepmc   +1 more source

Computer-Aided Discovery of Small-Molecule Inhibitors of Pathogenic New World Arenavirus Entry and Replication. [PDF]

ACS Infect Dis
Wasson SR, Flude BM, Salerno M, Jung KH, Padalino G, Ferla S, Roche-Dugmore DJ, Bott CW, Brancale A, Gowen BB, Bassetto M.   +10 more
europepmc   +1 more source

Catching our breath: development of interventions and therapies for respiratory syncytial virus. [PDF]

Microbiol Mol Biol Rev
Mathew AM, Neilsen G, Lan S, Shooter SL, Zheng JSJ, Estes J, Cao D, Schinazi RF, Singh US, Liang B, Lee S, Sarafianos SG.   +11 more
europepmc   +1 more source

Viral apoptotic mimicry and the role of phosphatidylserine receptors. [PDF]

mSphere
Brindley MA, Pisciotta MA.
europepmc   +1 more source

Lassa and Mopeia viruses produce different RIG-I-activating RNA in the absence of a functional viral exoribonuclease domain. [PDF]

J Virol
Noy K, Legendre R, Croze S, Najburg V, Fernandez R, Lucifora J, Lachuer J, Baize S, Komarova AV, Mateo M.   +9 more
europepmc   +1 more source

Effect of the AHR Inhibitor CH223191 as an Adjunct Treatment for Mammarenavirus Infections. [PDF]

Int J Mol Sci
Pelaez MA, Westover JB, Scharton D, García CC, Gowen BB.   +4 more
europepmc   +1 more source

Progress toward the development of Lassa vaccines. [PDF]

Expert Rev Vaccines
Ly H.
europepmc   +1 more source

Decoding the human CD4⁺ T cell epitope repertoire for Lassa fever virus reveals T cell-based pan-mammarenavirus vaccine candidates. [PDF]

Cell Rep Med
Lee Y, Siddiqui L, Tarke A, Kim M, Michaelis T, Macias M, Phillips E, Mallal S, Trevizani R, Frazier A, Scheuermann RH, Zuniga A, Zmasek C, Spurgers K, Akintunde G, Stonier SW, Gagliardi TB, Warfield K, Li H, Hastie KM, Saphire EO, Tan GS, Grifoni A, Sette A.   +23 more
europepmc   +1 more source